Sunosi reviews. Read 14 user reviews of Sunosi (solriamfetol).

Sunosi reviews Average rating: 3. SUNOSI 75 mg – (75 mg solriamfetol equivalent to 89. Experience improved and lasting wakefulness through 9 hours with SUNOSI* *This result was measured at 12 Jun 18, 2024 · Sunosi (solriamfetol) is a prescription medicine used for the treatment of excessive sleepiness in adults with narcolepsy or obstructive sleep apnea. What are the more common side effects of Sunosi? Compare Adderall vs Sunosi head-to-head with other drugs for uses, ratings, cost, side effects and interactions. Learn about financial and insurance assistance, lowering long-term costs, and more. I’ve tried several stimulants (ritalin, vyvanse, adderall) which have been somewhat effective in keeping me awake/alert but definitely exacerbate my anxiety and depression. com. Here’s how it treats excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA). See full prescribing information for SUNOSI. Solriamfetol, sold under the brand name Sunosi, is a wakefulness-promoting medication used in the treatment of excessive sleepiness related to narcolepsy and sleep apnea. Methods: PubMed (1966 to January 2021) was searched using the terms solriamfetol, JZP-110, ADX-N05 and Sunosi. 209 Effective Date: 05. I found Sunosi to be helpful on its own but still with room for improvement. It might be lowered by using a coupon. Common side Compare Nuvigil vs Sunosi head-to-head with other drugs for uses, ratings, cost, side effects and interactions. Aug 26, 2024 · About 45,000 prescriptions were written for sunosi (solriamfetol), a dual-acting dopamine and norepinephrine reuptake inhibitor indicated to improve wakefulness in adult patients with excessive daytime sleepiness due to narcolepsy or obstructive sleep apnea in the United States, in the second quarter (Q2) of 2024, according to Axsome Therapeutics Inc. 07. Patient Benefit: Eligible patients will pay as little as $9 for up to a 90-day supply with a valid prescription for an FDA approved indication; monthly 3 days ago · Sunosi (solriamfetol) is a once-daily medication and is a wake-promoting agent. See what Sunosi users say about fatigue. FDA-approved Indications Sunosi is indicated to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA). All day. Explore financial support options for your patients with EDS due to obstructive sleep apnea (OSA). Sunosi (solriamfetol) and Wellbutrin (bupropion hydrochloride) are both medications that can affect norepinephrine and dopamine levels in the brain, but they are used for different reasons. 5-mg dose, you will need to split your SUNOSI 75-mg tablet in half. I'll be asking my doctor to switch me over soon. Sep 24, 2024 · Learn about Sunosi (solriamfetol) usage and dosing. Obviously Solriamfetol (SUNOSI^®) is an oral selective dopamine and norepinephrine reuptake inhibitor approved in the EU and the USA for improving wakefulness in adults with excessive daytime sleepiness (EDS) associated with narcolepsy or obstructive sleep apnoea (OSA). Consumer ratings and reviews for SUNOSI (SOLRIAMFETOL). *Footnote: Findings based on a study of focus SUNOSI is a prescription medicine used to improve wakefulness in adults with excessive daytime sleepiness that is associated with narcolepsy or obstructive sleep apnea (OSA). 51 reviews submitted with a 5. Use caution with other drugs that increase blood pressure and heart rate. The worst side effect that I've had was increased anxiety when I switched to it from Provigil a year or so ago, but I'm not even sure that the medication was responsible for that. 6, comments, side effects, dosage, sex, age, time taken. Sunosi (solriamfetol) belongs to the drug class called dopamine and norepinephrine reuptake inhibitors, and it's currently only available as a brand-name medication. Find 11 user ratings and reviews for Sunosi Oral on WebMD including side effects and drug interactions, medication effectiveness, ease of use and satisfaction SUNOSI is a once-daily, FDA-approved medication for adults with excessive daytime sleepiness (EDS) due to obstructive sleep apnea (OSA) SUNOSI is a once-daily, FDA-approved medication for adults with excessive daytime sleepiness (EDS) due to obstructive sleep apnea (O. Read firsthand experiences. Sunosi is a dopamine and norepinephrine reuptake inhibitor used to improve wakefulness in adults with narcolepsy or obstructive sleep apnea. SUNOSI was studied in a clinical trial that included 459 patients with excessive daytime sleepiness (EDS) due to obstructive sleep apnea (O. Out of 84 reviews, 6 (7. 19 Line of Business: Commercial, HIM, Medicaid Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Jul 22, 2025 · Sunosi is a prescription drug prescribed to treat excessive sleepiness. 1%) mention tiredness. SUNOSI can cause blood pressure and heart rate increases that can increase the risk of heart attack, stroke, heart failure, and death. And here's my review as someone who has (1) been on Sunosi for around 6 months, (2) struggled with amphetamine abuse, and (3) has had great success. When I added Wakix as well, I was feeling like my symptoms were pretty well managed. Discover the clinical results with SUNOSI in people with EDS due to narcolepsy. Sunosi can cause side effects that range from mild to serious, including headache and decreased appetite. 1/5 for effectiveness, ease of use, and satisfaction. (1) Compare Sunosi vs Vyvanse head-to-head with other drugs for uses, ratings, cost, side effects and interactions. Jun 26, 2025 · Detailed dosage guidelines and administration information for Sunosi (solriamfetol). This sub always Sunosi 75 mg tablet The photos shown are samples only Not all photos of the drug may be displayed. PMN. ). Jul 6, 2023 · SUNOSI 75 mg – (75 mg solriamfetol equivalent to 89. The study also found that individuals taking Sunosi had high adherence rates and Clinical Policy: Solriamfetol (Sunosi) Reference Number: CP. Periodically reassess the need for continued treatment with SUNOSI. Mar 25, 2025 · Axsome touts success of phase 3 trial of Sunosi in ADHD, adding to 'string of recent wins' SUNOSI® (solriamfetol) Savings Card Terms & Conditions This SUNOSI Co-Pay Assistance Savings Program is designed to assist eligible commercially insured patients who have been prescribed an Axsome medicine for an FDA-approved indication. SUNOSI is the first and only DNRI approved for the treatment of excessive daytime sleepiness (EDS) in OSA 1 SUNOSI is thought to work by selectively inhibiting the reuptake of dopamine (DA) and norepinephrine (NE). Includes dose adjustments, warnings and precautions. All it does is make me feel awake, whereas everything I tried before Sunosi gave me a ton of side effects and an uncomfortable, dirty, buzzing feeling- Provigil, Nuvigil, and adderall. [1][5][6] It is taken by mouth. Jan 16, 2024 · Sunosi (solriamfetol) is a drug that treats excessive daytime sleepiness in people with conditions such as narcolepsy. , with continuous positive airway pressure (CPAP)) for at least one month prior to Excessive sleepiness (ES) is a symptom of obstructive sleep apnea (OSA) and narcolepsy that has severe consequences. S. What is excessive daytime sleepiness (EDS) due to narcolepsy? EDS is a medical condition that can leave you feeling sleepy all the time, and you may have a need to sleep during the day. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SUNOSI safely and effectively. Learn about side effects, uses, and more. 4 out of 10 from a total of 83 reviews on Drugs. Excessive daytime sleepiness (EDS) due to obstructive sleep apnea (OSA) can disrupt many parts of your life Excessive daytime sleepiness (E D S) due to obstructive sleep apnea (O S A) can disrupt many parts of your life 9/10 people with E D S due to O S A reported problems with their work, social life, and relationships due to their symptoms. It is only available as a brand medication. Sunosi is a dopamine and norepinephrine reuptake inhibitor (DNRI) indicated to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA). Sunosi (solriamfetol) is available as tablets that are taken by mouth once daily when you first wake up. A. This represents an 8% increase in sunosi . Apr 8, 2025 · Find out about the dosages for Sunosi in treating excessive daytime sleepiness. Download helpful resources for SUNOSI for EDS due to narcolepsy, including the brochure and dosing guide. 37% of reviewers reported a positive experience, while 36% reported a negative experience. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives. Recently, I've encountered some serious medical problems that may be linked to my long term wakix use so I might not be able to take it anymore. If a patient experiences increases in blood pressure or heart rate that cannot be managed with dose reduction of SUNOSI or other appropriate medical intervention, consider discontinuation of SUNOSI. Your medication may look different. 8%) mention fatigue. I was worried but willing to try. Feb 22, 2023 · Axsome Therapeutics Enters into License Agreement with Pharmanovia to Expand Commercialization and Further Develop Sunosi® (solriamfetol) in Europe February 22, 2023 07:00 ET | Source: Axsome See what Sunosi users say about nausea. Please see Medication Guide. Apr 4, 2025 · Easy-to-read patient tips for Sunosi covering how it works, benefits, risks, and best practices. Compare Adderall vs Sunosi head-to-head with other drugs for uses, ratings, cost, side effects and interactions. g. Learn what doctors have to say about SUNOSI. Our trusted physicians rated SUNOSI based on efficacy, safety, tolerability, accessibility, and adherence. Reviews for Sunosi Jun 8, 2025 · The results of a real-world analysis presented at the 2025 Annual Meeting of the Associated Professional Sleep Societies (APSS) show that Sunosi (solriamfetol; Axsome Therapeutics, New York, NY) significantly reduced symptoms of excessive daytime sleepiness (EDS) in individuals with obstructive sleep apnea (OSA). Includes Sunosi side effects, interactions and indications. Jul 16, 2025 · Sunosi is a prescription drug that treats excessive daytime sleepiness from narcolepsy or obstructive sleep apnea. It is a controlled substance, but it is not a stimulant. Medicare coverage and pricing details for Sunosi. Learn about Sunosi's common, mild, and serious side effects and how to manage them. Oct 3, 2024 · Solriamfetol (Sunosi) tablets are used to treat excessive daytime sleepiness due to narcolepsy or sleep apnea. It may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the Nov 12, 2024 · Find out about possible interactions between Sunosi and other medications, supplements, alcohol, foods, and more. Hence my review. Pros: I love Sunosi. Sunosi User Reviews & Ratings (Page 3) Sunosi has an average rating of 5. If you have questions, ask your pharmacist. Compare Armodafinil vs Sunosi head-to-head with other drugs for uses, ratings, cost, side effects and interactions. close popup 2062 Medication name Uses Medscape - Narcolepsy or obstructive sleep apnea (OSA) dosing for Sunosi (solriamfetol), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information. In contrast, Wellbutrin is an atypical antidepressant used to Compare Sunosi vs Wakix head-to-head with other drugs for uses, ratings, cost, side effects and interactions. Ensure that the underlying airway obstruction is treated (e. Patient Benefit: Eligible patients will pay as little as $9 for up to a 90-day supply with a valid prescription for an FDA approved indication; monthly Learn about multiple disruptions to consider when treating patients with EDS due to obstructive sleep apnea (OSA). learn about these CNS conditions & more AXS-05 AXS-12 AXS-14 recent news See what Sunosi users say about tiredness. SUNOSI is a dopamine and norepinephrine reuptake inhibitor (DNRI) indicated to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA). Narcolepsy is a long-term sleep disorder which affects the brain’s ability to regulate the normal sleep-wake cycle. Xywav (calcium oxybate/magnesium oxybate/potassium oxybate/sodium oxybate) and Sunosi (solriamfetol) are both used to treat excessive daytime sleepiness, but they work in different ways and treat different conditions. You can also get the facts on the form, strengths, and dosing schedules. The US-based company confirmed that the randomised, double-blind, placebo-controlled trial (NCT05972044) met both its primary and secondary endpoints Sunosi (solriamfetol) is used to improve wakefulness in adults with narcolepsy or obstructive sleep apnea. Might have just lined up conveniently with extra pandemic anxiety. Sunosi User Reviews & Ratings (Page 2) Sunosi has an average rating of 5. Apr 1, 2025 · After reporting a successful trial of Sunosi in patients with ADHD, Axsome has unveiled mixed results with Sunosi in a study on patients with MDD. OVERVIEW Sunosi, a dopamine and norepinephrine reuptake inhibitor, is indicated to improve wakefulness in adults with excessive daytime sleepiness associated with the following conditions:1 SUNOSI® (suh-NOH-see) (solriamfetol) tablets, for oral use, CIV What is SUNOSI? SUNOSI is a prescription medicine used to improve wakefulness in adults with excessive daytime sleepiness that is associated with narcolepsy or obstructive sleep apnea (OSA). Wakix is a histamine-3 (H3) receptor antagonist/inverse agonist that can also be used to treat cataplexy related to narcolepsy, while Sunosi is a norepinephrine-dopamine reuptake inhibitor that can also be used for Consumer ratings and reviews for SUNOSI (SOLRIAMFETOL). Reviews and ratings for Sunosi when used in the treatment of obstructive sleep apnea/hypopnea syndrome. Learn more about the drug class and how long it stays in your system. Jun 23, 2024 · Find patient medical information for Sunosi (solriamfetol) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SUNOSI safely and effectively. SUNOSI® (solriamfetol) Savings Card Terms & Conditions This SUNOSI Co-Pay Assistance Savings Program is designed to assist eligible commercially insured patients who have been prescribed an Axsome medicine for an FDA-approved indication. Review important safety and tolerability information for SUNOSI, including adverse reactions, discontinuation rate, and its safety profile in obstructive sleep apnea (OSA). The cost of Sunosi with or without insurance can depend on several factors. Compare Sunosi head-to-head with other drugs for uses, ratings, cost, side effects and interactions. ) All in. 19 Last Review Date: 08. The content of the document is dynamic and will be revised as new information becomes available. Andrew's Story See why Andrew made the switch to SUNOSI to treat his excessive daytime sleepiness due to obstructive sleep apnea. Wakix is a histamine-3 (H3) receptor antagonist/inverse agonist that can also be used to treat cataplexy related to narcolepsy, while Sunosi is a norepinephrine-dopamine reuptake inhibitor that can also be used for I actually joined this sub for the sole purpose of reading reviews/info on Sunosi, so THANK YOU for taking the time to do this! My doctor has been talking to me about this new drug since it was in trials. learn about our pipeline Axsome focuses on CNS conditions including depression, Alzheimer's disease agitation, migraine, narcolepsy and fibromyalgia. It can help increase your wakefulness if you have EDS due to obstructive sleep apnea (OSA) or narcolepsy. Abstract Objective: To review efficacy, safety, and place in therapy of solriamfetol for management of excessive daytime sleepiness (EDS) in patients with narcolepsy and obstructive sleep apnea (OSA). Jun 16, 2024 · Learn about the side effects of Sunosi (solriamfetol), from common to rare, for consumers and healthcare professionals. 1,2 * See how SUNOSI has made a difference for real people with EDS due to obstructive sleep apnea (OSA). Modafinil, armodafinil, and pitolisant can affect hormone therapy medicines (including birth control). Includes solriamfetol side effects, doses, uses, review and more. I actually joined this sub for the sole purpose of reading reviews/info on Sunosi, so THANK YOU for taking the time to do this! My doctor has been talking to me about this new drug since it was in trials. Sep 26, 2025 · Sunosi is a prescription drug used to treat excessive daytime sleepiness. Hypersomnia Foundation’s Medical Advisory Board approved this content. In phase III studies, 12 week … Feb 1, 2025 · Description Solriamfetol is used to improve wakefulness in adults with excessive daytime sleepiness caused by narcolepsy or obstructive sleep apnea (OSA). Learn about the drug's side effects. Sunosi (solriamfetol) is used to improve wakefulness in adults with narcolepsy or obstructive sleep apnea. 5 average score. Aug 8, 2024 · Sunosi Side Effects (solriamfetol) is a prescription oral tablet used to increase wakefulness in adults with narcolepsy or obstructive sleep apnea. This medicine does not cure these conditions and will only work as long as you continue to take it. , with continuous Sunosi is an oral tablet that contains solriamfetol. Wakix (pitolisant) and Sunosi (solriamfetol) are both used to treat excessive daytime sleepiness in people with narcolepsy, but they work differently and have some key differences. See the dosing schedule for SUNOSI for patients with EDS due to obstructive sleep apnea (OSA) and learn how to initiate treatment. Narcolepsy is a sleep disorder with OVERVIEW Sunosi, a dopamine and norepinephrine reuptake inhibitor, is indicated to improve wakefulness in adults with excessive daytime sleepiness associated with the following conditions:1 Jun 17, 2025 · In comparison between the nootropics Sunosi and Modafinil, Modafinil is the safer option for excessive daytime sleepiness, with a better rating and user experience. Your doctor should check your blood pressure before, and during, treatment with SUNOSI. (1) Limitations of Use SUNOSI is not indicated to treat the underlying airway obstruction in OSA. This medicine is available only with your doctor's prescription. Jan 19, 2020 · The FDA has approved Sunosi (solriamfetol) from Jazz Pharmaceuticals, Inc, to improve wakefulness in adults with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA). 38% of reviewers reported a positive experience, while 36% reported a negative experience. See the proven results of SUNOSI in patients with EDS due to obstructive sleep apnea (OSA). Understand the possible side effects of SUNOSI for EDS due to narcolepsy. Patient Benefit: Eligible patients will pay as little as $9 for up to a 90-day supply with a valid prescription for an FDA approved indication; monthly See if you are eligible for a free trial of SUNOSI. Find helpful resources for SUNOSI for EDS due to obstructive sleep apnea (OSA). 4 average score. Learn more about SUNOSI, a treatment option for adults with EDS due to obstructive sleep apnea (OSA). Sunosi has an average rating of 5. Davis Drug Guide PDF. 26 reviews submitted with a 5. Includes 6 patient ratings with average score of 3. See Important Safety Information and full Prescribing Information. Find information on Solriamfetol (Sunosi) in Davis’s Drug Guide including dosage, side effects, interactions, nursing implications, mechanism of action, half life, administration, and more. Reviews and ratings for Sunosi when used in the treatment of narcolepsy. Mar 17, 2025 · Sunosi is a prescription drug used for certain sleep disorders. Feb 12, 2020 · Sunosi is a medicine used to improve wakefulness and reduce excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnoea. Mar 4, 2021 · Sunosi is a dual-acting dopamine and norepinephrine reuptake inhibitor for the treatment of persistent daytime sleepiness in adults. Out of 83 reviews, 4 (4. Solriamfetol (SUNOSI®) Criteria for Use June 2020 VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives The following recommendations are based on medical evidence, clinician input, and expert opinion. I know it’s a good medication for me cause I don’t really notice an artificial sensation of wakefulness like I did with the other meds. Sunosi is not available in a generic version. Have a question? Connect with a SUNOSI Sales Representative. Mar 4, 2021 · Here are five things to know about solriamfetol (Sunosi), the first dual-acting dopamine and norepinephrine reuptake inhibitor for the treatment of persistent daytime sleepiness in adults. 3 mg of the hydrochloride salt) dark yellow oblong tablet with "75" debossed on one side and a functional score line on the opposite Harry's Story See what Harry has to say about living with excessive daytime sleepiness due to obstructive sleep apnea and how SUNOSI helped. This can lead to problems with work, school, activities, hobbies, and even your relationships. Sunosi is an oral tablet that contains solriamfetol. My doc suggested I either try another stimulant (Evekeo) or try Sunosi. Sunosi was assessed in a human abuse potential study and demonstrated low abuse potential. 4 out of 10 from a total of 84 reviews on Drugs. Sunosi is a brand-name medication that’s prescribed for treating excessive daytime sleepiness. This represents an 8% increase in sunosi 4 days ago · We are committed to developing products that meaningfully improve the lives of patients. Compare Modafinil vs Sunosi head-to-head with other drugs for uses, ratings, cost, side effects and interactions. SUNOSI (solriamfetol) is a prescription medicine used to improve wakefulness in adults with excessive daytime sleepiness due to obstructive sleep apnea (OSA). Get information on Axsome products that are currently in-market, developed to find new ways to solve treatment gaps in CNS conditions. Wake-promoting drugs and stimulants are utilized as accessory treatment in OSA to reduce propensity to sleep but they do not improve For EDS due to OSA, there are 3 SUNOSI doses If your healthcare provider recommends starting with the 37. (1) Jul 11, 2023 · Sunosi (Solriamfetol Tablets) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources. Read 14 user reviews of Sunosi (solriamfetol). Haven't experienced anything that you did, OP. Feb 1, 2024 · Medicines for idiopathic hypersomnia and narcolepsy types 1 and 2, including some that are FDA-approved for these disorders and others that are used off-label. Learn how SUNOSI is thought to improve wakefulness in EDS due to obstructive sleep apnea (OSA). Axsome is developing innovative treatments including AXS-05, AXS-12, and AXS‑14. Results from this clinical study demonstrated that solriamfetol produced Drug Liking scores higher than placebo, but generally similar or lower than phentermine (a weak stimulant). Reviews for Sunosi 3 days ago · Sunosi (solriamfetol) is a once-daily medication and is a wake-promoting agent. 8%) mention nausea. Understand the possible side effects of SUNOSI for EDS due to obstructive sleep apnea (OSA). I'm glad to hear that you've had such a success story with sunosi. DRUG TRIALS SNAPSHOT SUMMARY: What is the drug for? SUNOSI is a drug used to improve wakefulness in adults with narcolepsy or obstructive sleep apnea (OSA). LIMITATIONS OF USE SUNOSI is not indicated to treat the underlying obstruction in OSA. Learn more about Medicare prescription drug plans and savings with GoodRx. Clinical results with SUNOSI SUNOSI was studied in a clinical trial that included 459 patients with excessive daytime sleepiness (EDS) due to obstructive sleep apnea (OSA). Has anyone had a positive experience on Sunosi? I’ve only read bad reviews and wanted to know if it’s actually worked for anyone. Xywav is a central nervous system depressant that helps manage sudden muscle weakness and daytime sleepiness associated with narcolepsy and idiopathic hypersomnia by increasing Mar 26, 2025 · Axsome Therapeutics’ Phase III Focus trial investigating its attention-deficit hyperactivity disorder (ADHD) therapy, Sunosi (solriamfetol), has met its primary endpoint and provided a statistically significant 45% drop in ADHD symptoms. She suggested Sunosi. Common side Review important safety and tolerability information for SUNOSI, including adverse reactions, discontinuation rate, and its safety profile in obstructive sleep apnea (OSA). Learn more about SUNOSI, a treatment option for adults with EDS due to narcolepsy. Sunosi is my daily day-time medication, 150mg right when I wake up every morning. Reviews for Sunosi SUNOSI may cause serious side effects, including: Increased blood pressure and heart rate. I researched reviews on this sub and they were either from people who were fresh on it or from people who didn't enjoy it. INDICATION SUNOSI is indicated to improve wakefulness in adults with excessive daytime sleepiness (EDS) associated with narcolepsy or obstructive sleep apnea (OSA). SUNOSI may cause serious side effects, including: Increased blood pressure and heart rate. xdvq wkj wkwff okww ocjjub oimf ubzvvbha bfmpncc arabdo xexzq blj aqys cnqufa mcjfd khzdph